These biotech IPOs plan to move forward during shutdown © 2025 American City Business Journals. All rights reserved. Use of ...

Before medicines and new treatment methods become available to the public, they undergo clinical trials, which is part of the ...

Neurologists at Florida Atlantic University have launched a new research tool combining focused ultrasound and magnetic ...

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced results from the ...

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

Texans live with dementia. If voters approve Prop 14, patients will get access to early intervention treatments, more ...

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...

A new study led by the University of Bristol, involving more than one million participants, has found that having lower cholesterol levels may reduce the risk of developing dementia. The study, led by ...

The effectiveness of eye-tracking technology in identifying people who have a genetic tendency to Alzheimer's disease, years ...

Alector (ALEC) announced results from the Phase 3 INFRONT-3 clinical trial evaluating latozinemab in individuals with frontotemporal dementia due ...

A large study shows risperidone raises stroke risk in patients with dementia, even those without cardiovascular disease — ...

Genetic analysis reveals people with higher alcohol consumption have 15-16% greater dementia risk, suggesting reducing ...